These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22539572)

  • 1. Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.
    Cereda E; Barichella M; Cassani E; Caccialanza R; Pezzoli G
    Neurology; 2012 May; 78(19):1507-11. PubMed ID: 22539572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
    Ozekmekçi S; Apaydin H; Kiliç E
    Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
    J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses.
    Louis ED; Levy G; Côte LJ; Mejia H; Fahn S; Marder K
    Mov Disord; 2002 May; 17(3):513-7. PubMed ID: 12112199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.
    Iacovelli E; Gilio F; Meco G; Fattapposta F; Vanacore N; Brusa L; Giacomelli E; Gabriele M; Rubino A; Locuratolo N; Iani C; Pichiorri F; Colosimo C; Carbone A; Palleschi G; Inghilleri M
    Mov Disord; 2010 Jul; 25(9):1203-9. PubMed ID: 20310046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in Parkinson's disease.
    Lyons KE; Hubble JP; Tröster AI; Pahwa R; Koller WC
    Clin Neuropharmacol; 1998; 21(2):118-21. PubMed ID: 9579298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lifestyle regularity measured by the social rhythm metric in Parkinson's disease.
    Câmara Magalhães S; Vitorino Souza C; Rocha Dias T; Felipe Carvalhedo de Bruin P; de Bruin VM
    Chronobiol Int; 2005; 22(5):917-24. PubMed ID: 16298776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actigraphy monitoring of symptoms in patients with Parkinson's disease.
    Pan W; Kwak S; Li F; Wu C; Chen Y; Yamamoto Y; Cai D
    Physiol Behav; 2013 Jul; 119():156-60. PubMed ID: 23748129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease--a study from Southwest China.
    Guo X; Song W; Chen K; Chen X; Zheng Z; Cao B; Huang R; Zhao B; Wu Y; Shang HF
    Parkinsonism Relat Disord; 2013 Nov; 19(11):961-5. PubMed ID: 23849500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep disorders in Parkinson's disease.
    Kumar S; Bhatia M; Behari M
    Mov Disord; 2002 Jul; 17(4):775-81. PubMed ID: 12210875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of familial structure on Parkinson's disease in Istanbul Medical School, Turkey.
    Lohmann E; Hanağası HA; Gürvit H; Kayacı G; Ruberg M; Yazıcı J; Emre M
    Int J Neurosci; 2012 Feb; 122(2):102-5. PubMed ID: 21995451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-year population-based study of psychosis in Parkinson disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Goetz CG; Stebbins GT; Aarsland D; Alves G
    Arch Neurol; 2010 Aug; 67(8):996-1001. PubMed ID: 20697051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional capacity of Brazilian patients with Parkinson's disease (PD): relationship between clinical characteristics and disease severity.
    Barbieri FA; Rinaldi NM; Santos PC; Lirani-Silva E; Vitório R; Teixeira-Arroyo C; Stella F; Gobbi LT;
    Arch Gerontol Geriatr; 2012; 54(2):e83-8. PubMed ID: 21963176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
    Kenangil G; Orken DN; Ur E; Forta H; Celik M
    Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.